Our @MarinaPieri4 now presenting at @EACTAIC webinar: native heart recovery is the first choice option! ImageImageImageImage
2 RCTs are running on #levosimendan in VE #ECMO weaning @EACTAIC

Dieter Dauwe Image
In a patient with #ECPELLA #ECMELLA

Which device do you wean first?
#ECMO or #IMPELLA

Dieter Dauwe @DauweDieter
@EACTAIC @MarinaPieri4 Image
conclusions by @DauweDieter Image
Dr Evgeny Potapov from Berlin showing impressive numbers and interesting trends of #LVAD and #IMPELLA implantations in Germany ImageImageImageImage
Interesting trends in #ECMELLA #IMPELLA over the years
by Evgeny Potapov
@EACTAIC Image
Conclusions by Dr Evgeny Potapov

Hundreds of participants into this @EACTAIC seminar

thanks @tahan_dr for the perfect organization Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with San Raffaele Anesthesia and Intensive Care

San Raffaele Anesthesia and Intensive Care Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @SRAnesthesiaICU

Apr 18
🚫 DON’T use glucocorticoids in oxygen-free #COVID19 pts

Just published @NEJMEvidence
 
Guidelines are against glucocorticoids in pts not on O2 but effect on survival remains unclear
 
Our meta-analysis found that glucocorticoids increase mortality

🔗eviden.cc/3MnrDSA 1/5 Image
2/

📝 STUDY SELECTION
 
P: adults with #COVID19 not receiving oxygen
I: intravenous or oral #glucocorticoids
C: any
O: all-cause mortality at the longest follow-up available
S: RCTs, matched studies
 
➡️ 5 RCTs and 1 propensity-matched study (total 6634 pts) were included Image
3/

🪦 MORTALITY: #Glucocorticoids vs comparator

14% vs 10% (OR=1.56; 95% CI=1.27 to 1.93)
Number needed to harm=27
 
Mortality increase was confirmed in RCTs only
16% vs 13% (OR=1.34; 95% CI=1.00 to 1.78)
 
Need for mechanical ventilation was also increased: 18% vs 15%

#FOAMcc Image
Read 5 tweets
Jun 18, 2021
Inoperable patients can now be offered a potentially curative surgery.

🔗 Read @annalsthorsurg: pubmed.ncbi.nlm.nih.gov/34111383/ and the thread 👇 #FOAMcc #FOAMecmo
2/

Here we report the 1st case of intraoperative use of VA-#ECMO in a patient with resectable lung cancer and bivasal critical coronary artery disease with prohibitive low EF (23%), and describe the benefits of this new indication.

🔗 pubmed.ncbi.nlm.nih.gov/34111383/ #FOAMcc #FOAMecmo
3/

Cardiovascular comorbidities often prevent patients with otherwise resectable early-stage lung cancer from undergoing surgery due to prohibitive peri-operative risk.
Read 8 tweets
Jan 21, 2021
1/

In non-COVID-19 pneumonia/ARDS filling defects are found in pulmonary arteries branches vascularizing healthy lung segments. Instead, in #COVID19 there is an almost perfect topographical overlap of filling defects distribution & pneumonia extent.

🔗 jcvaonline.com/article/S1053-…
2/

We demonstrated that pulmonary vascular thrombosis in #COVID19 is due to local inflammatory endothelial damage with a superimposed thrombotic late complication and not to recurrent thromboembolism from peripheral deep vein thrombosis.

#MicroCLOTS
3/

51% of pts showed pulmonary vascular thrombosis, with a median time from symptoms of 18 days.

We identified a specific radiological pattern of #COVID19 pneumonia with a unique spatial distribution of pulmonary vascular thrombosis overlapping areas of ground-glass opacities.
Read 7 tweets
Aug 3, 2020
How we’ll we manage the first ten #COVID19 patients of 2021 (if any) hospitalized for #ARDS (compared to the first 10 patients we managed in February 2020). A multidisciplinary brain storming after managing approx 1000 such patients within the end of Apr 2020. A thread 1/ #FOAMed Image
2/
Not all our clinical impressions have already published evidence (but the majority was published), but our hospital #COVID19 mortality went close to zero in late April 2020 and we hope medical management accounts for at least part of these results.
3/
More, early ECMO. We put a dozen ECMO. We feel we should have put more of them and we should have done it earlier (eg after a couple of days of invasive mechanical ventilation with no improvement). @annamarascandro
@mgcalabroMD @md_monaco @MarinaPieri4
hsr.it/news/2020/magg…
Read 11 tweets
Apr 24, 2020
[THREAD]

We just published the largest, most detailed case series of mechanically ventilated #COVID19 patients with ARDS in a western country and with the longest follow-up.

Read our infographic & the article on @CCRJournal bit.ly/2SiXYgD

#COVIDFOAM #FOAMed #FOAMcc
2/7
Mortality of ICU mechanically ventilated patients with #COVID19 ARDS is as high as 23% at the 20 days follow-up.

#COVIDFOAM #FOAMed #FOAMcc
3/7
Acute kidney injury (75%) and secondary bacteremia (37%) are the most frequent complications of #COVID19 ARDS.

Also, pneumothorax, pneumomediastinum, and thromboembolic complications were relatively common.

#COVIDFOAM #FOAMed #FOAMcc
Read 7 tweets
Mar 4, 2020
How to administer oxygen worldwide in March 2020 to minimize viral dispersion: Tricks and Tips. #COVID19 #Coronavirus #COVID19foam #FOAMed #FOAMcc Thread 1/6 ImageImageImage
When using nasal cannula or High Flow Nasal Cannula consider adding a simple disconnected face mask as a shield to prevent viral spreading. #COVID19 #Coronavirus #COVID19foam #FOAMed #FOAMcc Thread 2/6 Image
According to Hui et al. High Flow Nasal Cannula could have higher risk of aerosol dispersion in mannequin study. #COVID19 #Coronavirus #COVID19foam #FOAMed #FOAMcc Thread 3/6

pubmed.ncbi.nlm.nih.gov/25224111/ Image
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(